Latest GMTX reports update at 2024-03-21: 2023 ∙ 2022
  1. Home
  2. Stock quotes
  3. Stock Gemini Therapeutics
Gemini Therapeutics logo

Gemini Therapeutics GMTX

$ 1.56 0.97%
mail-toReport an Error

Country

 usaUSA

IPO year

 -

Industry

 -

Stock Exchange

 NASDAQ GLOBAL

CEO

 -

Employees in the company

 -

Shares

 22.3 M

Market Cap[1]

 $ 67.4 M

EBITDA (LTM)

 $ -57.5 M

P/E (LTM)

 -0.08

P/S (LTM)

 -

EPS (LTM)

 -19.34

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.